Green tea aroma fraction reduces β-amyloid peptide-induced toxicity in Caenorhabditis elegans transfected with human β-amyloid minigene

References

• FujikiH, ImaiK, NakachiK, ShimizuM, MoriwakiH, SuganumaM. Challenging the effectiveness of green tea in primary and tertiary cancer prevention. J. Cancer Res. Clin. Oncol. 2012;138:1259–1270.10.1007/s00432-012-1250-y
   PubMed Web of Science ®Google Scholar
• ImaiK, NakachiK. Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ. 1995;310:693–696.10.1136/bmj.310.6981.693
   PubMed Web of Science ®Google Scholar
• NakachiK, MatsuyamaS, MiyakeS, SuganumaM, ImaiK. Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. Biofactors. 2000;13:49–54.10.1002/biof.v13:1/4
   PubMed Web of Science ®Google Scholar
• SueokaN, SuganumaM, SueokaE, OkabeS, MatsuyamaS, ImaiK, NakachiK, FujikiH. A new function of green tea: prevention of lifestyle-related diseases. Ann. NY Acad. Sci. 2001;928:274–280.
   PubMed Web of Science ®Google Scholar
• SuganumaM, OkabeS, SueokaN, SueokaE, MatsuyamaS, ImaiK, NakachiK, FujikiH. Green tea and cancer chemoprevention. Mutation Res. 1999;428:339–344.10.1016/S1383-5742(99)00059-9
   PubMed Web of Science ®Google Scholar
• SuganumaM, OkabeS, KaiY, SueokaN, SueokaE, FujikiH. Synergistic effects of (-)-epigallocatechin gallate with (-)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. Cancer Res. 1999;59:44–47.
   PubMed Web of Science ®Google Scholar
• HattoriS. Study of new approach for evaluation of Japanese green tea using OASIS method. Memoirs of the Faculty of Agricutlure Hokkaido University (in Japanese). 2006;28:85–120.
   Google Scholar
• YamanishiT. Flavor of tea. Food Rev. Int. 1995;11:477–525.
   Google Scholar
• Prakash ChaturvedulaVS, PrakashI. The aroma, taste, color and bioactive constituents of tea. J. Med. Plant Res. 2011;5:2110–2124.
   Google Scholar
• JumteeK, KomuraH, BambaT, FukusakiE. Predication of Japanese green tea (Sen-cha) ranking by volatile profiling using gas chromatography mass spectrometry and multivariate analysis. J. Biosci. Bioeng. 2011;112:252–255.10.1016/j.jbiosc.2011.05.008
   PubMed Web of Science ®Google Scholar
• HasegawaT. Separation of odor constituents by microscale fractional bulb-to-bulb distillation. In: In distillation-advances from modeling to applications. SZereshki, editor. Croatia: In Tech; 2012. p. 199–210.
   Google Scholar
• HasegawaT, KishiY, KatoY, AkutsuK, JinguD, TakahashiA, TanakaE, NakajimaK, MatsumotoT. Comparison between aroma profiles of green tea leaves and black tea leaves derived from ‘Sayamakaori’. In proceedings of the 4th international conference on O-CHA (Tea) culture and science; 2010 October 26–28; Shizuoka; 2011. p. 1–2.
   Google Scholar
• CummingsJL. Alzheimer’s disease. New England J. Med. 2004;351:56–67.
   PubMed Web of Science ®Google Scholar
• MählerA, MandelS, LorenzM, RueggU, WankerEE, BoschmannM, PaulF. Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases?EPMA J.2013;4:5.10.1186/1878-5085-4-5
   PubMedGoogle Scholar
• ArnoldSE, LounevaN, CaoK, WangLS, HanLY, WolkDA, NegashS, LeurgansSE, SchneiderJA, BuchmanAS, WilsonRS, BennettDA. Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease. Neurobiol. Aging. 2013;34:157–168.10.1016/j.neurobiolaging.2012.03.004
   PubMed Web of Science ®Google Scholar
• HardyJ, Chartier-HarlinMC, MullanM. Alzheimer disease: the new agenda. Am. J. Human Genet. 1992;50:648–651.
   PubMed Web of Science ®Google Scholar
• HardyJ, SelkoeDJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002;297:353–356.10.1126/science.1072994
   PubMed Web of Science ®Google Scholar
• EhrnhoeferDE, BieschkeJ, BoeddrichA, HerbstM, MasinoL, LurzR, EngemannS, PastoreA, WankerEE. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat. Struct. Mol. Biol. 2008;15:558–566.10.1038/nsmb.1437
   PubMed Web of Science ®Google Scholar
• BieschkeJ, RussJ, FriedrichRP, EhrnhoeferDE, WobstH, NeugebauerK, WankerEE. EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity. Proc. Nat. Acad. Sci. 2010;107:7710–7715.10.1073/pnas.0910723107
   PubMed Web of Science ®Google Scholar
• BrownMK, EvansJL, LuoY. Beneficial effects of natural antioxidants EGCG and α-lipoic acid on life span and age-dependent behavioral declines in Caenorhabditis elegans. Pharmacol. Biochem. Behav. 2006;85:620–628.10.1016/j.pbb.2006.10.017
   PubMed Web of Science ®Google Scholar
• LinkCD, TaftA, KapulkinV, DukeK, KimS, FeiQ, WoodDE, SahaganBG. Gene expression analysis in a transgenic Caenorhabditis elegans Alzheimer's disease model. Neurobiol. Aging. 2003;24:397–413.10.1016/S0197-4580(02)00224-5
   PubMed Web of Science ®Google Scholar
• WuY, WuZ, ButkoP, ChristenY, LambertMP, KleinWL, LinkCD, LuoY. Amyloid-β-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans. J. Neurosci. 2006;26:13102–13113.10.1523/JNEUROSCI.3448-06.2006
   PubMed Web of Science ®Google Scholar
• AlavezS, VantipalliMC, ZuckerDJ, KlangIM, LithgowGJ. Amyloid-binding compounds maintain protein homeostasis during ageing and extend lifespan. Nature. 2011;472:226–229.10.1038/nature09873
   PubMed Web of Science ®Google Scholar
• ChoSC, ParkMC, KeamB, ChoiJM, ChoY, HyunS, ParkSC, LeeJ. DDS, 4,4′-diaminodiphenylsulfone, extends organismic lifespan. Proc. Nat. Acad. Sci. 2010;107:19326–19331.10.1073/pnas.1005078107
   PubMed Web of Science ®Google Scholar
• BrennerS. The genetics of Caenorhabditis elegans. Genetics. 1974;77:71–94.
   PubMed Web of Science ®Google Scholar
• DostalV, LinkCD. Assaying β-amyloid toxicity using a transgenic C. elegans model. J. Vis. Exp. 2010;44. pii:2252, doi:10.3791/2252.
   PubMedGoogle Scholar
• WoodJG, RoginaB, LavuS, HowitzK, HelfandSL, TatarM, SinclairD. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature. 2004;430:686–689.10.1038/nature02789
   PubMed Web of Science ®Google Scholar
• TsushidaT, SuzukiM, KurogiM. Evaluation of antioxidant activity of vegetable extracts and determination of some active compounds. Nippon Shokuhin Kogyo Gakkaishi. ( in Japanese). 1994;41:611–618.10.3136/nskkk1962.41.611
   Web of Science ®Google Scholar
• SungS, YaoY, UryuK, YangH, LeeVM, TrojanowskiJQ, PraticoD. Early vitamin E supplementation in young but not aged mice reduces Aβ levels and amyloid deposition in a transgenic model of Alzheimer's disease. FASEB J. 2004;18:323–325.
   PubMed Web of Science ®Google Scholar
• NakashimaH, IshiharaT, YokotaO, TeradaS, TrojanowskiJQ, LeeVM, KurodaS. Effects of α-tocopherol on an animal model of tauopathies. Free Radical Biol. Med. 2004;37:176–186.10.1016/j.freeradbiomed.2004.04.037
   PubMed Web of Science ®Google Scholar
• NunomuraA, CastellaniRJ, ZhuX, MoreiraPI, PerryG, SmithMA. Involvement of oxidative stress in Alzheimer disease. J. Neuropathol. Exp. Neurol.2006;65:631–641.10.1097/01.jnen.0000228136.58062.bf
   PubMed Web of Science ®Google Scholar
• KuzuharaT, SuganumaM, FujikiH. Green tea catechin as a chemical chaperone in cancer prevention. Cancer Lett. 2008;261:12–20.10.1016/j.canlet.2007.10.037
   PubMed Web of Science ®Google Scholar
• FreireRS, MoraisSM, Catunda-JuniorFE, PinheiroDC. Synthesis and antioxidant, anti-inflammatory and gastroprotector activities of anethole and related compounds. Bioorg. Med. Chem. 2005;13:4353–4358.10.1016/j.bmc.2005.03.058
   PubMed Web of Science ®Google Scholar
• ZandiPP, AnthonyJC, KhachaturianAS, StoneSV, GustafsonD, TschanzJT, NortonMC, Welsh-BohmerKA, BreitnerJC. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch. Neurol. 2004;61:82–88.10.1001/archneur.61.1.82
   PubMed Web of Science ®Google Scholar